Literature DB >> 12874019

Identifying tumor origin using a gene expression-based classification map.

Phillip Buckhaults1, Zhen Zhang, Yu-Chi Chen, Tian-Li Wang, Brad St Croix, Saurabh Saha, Alberto Bardelli, Patrice J Morin, Kornelia Polyak, Ralph H Hruban, Victor E Velculescu, Ie-Ming Shih.   

Abstract

Identifying the primary site in cases of metastatic carcinoma of unknown origin has profound clinical importance in managing cancer patients. Although transcriptional profiling promises molecular solutions to this clinical challenge, simpler and more reliable methods for this purpose are needed. A training set of 11 serial analysis of gene expression (SAGE) libraries was analyzed using a combination of supervised and unsupervised computational methods to select a small group of candidate genes with maximal power to discriminate carcinomas of different tissue origins. Quantitative real-time PCR was used to measure their expression levels in an independent validation set of 62 samples of ovarian, breast, colon, and pancreatic adenocarcinomas and normal ovarian surface epithelial controls. The diagnostic power of this set of genes was evaluated using unsupervised cluster analysis methods. From the training set of 21,321 unique SAGE transcript tags derived from 11 libraries, five genes were identified with expression patterns that distinguished four types of adenocarcinomas. Quantitative real-time PCR expression data obtained from the validation set clustered tumor samples in an unsupervised manner, generating a self-organized map with distinctive tumor site-specific domains. Eighty-one percent (50 of 62) of the carcinomas were correctly allocated in their corresponding diagnostic regions. Metastases clustered tightly with their corresponding primary tumors. A classification map diagnostic of tumor types was generated based on expression patterns of five genes selected from the SAGE database. This expression map analysis may provide a reliable and practical approach to determine tumor type in cases of metastatic carcinoma of clinically unknown origin.

Entities:  

Mesh:

Year:  2003        PMID: 12874019

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  35 in total

1.  Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression test.

Authors:  Federico A Monzon; Fabiola Medeiros; Maureen Lyons-Weiler; W David Henner
Journal:  Diagn Pathol       Date:  2010-01-13       Impact factor: 2.644

2.  Notch3 overexpression is related to the recurrence of ovarian cancer and confers resistance to carboplatin.

Authors:  Joon Tae Park; Xu Chen; Claes G Tropè; Ben Davidson; Ie-Ming Shih; Tian-Li Wang
Journal:  Am J Pathol       Date:  2010-07-29       Impact factor: 4.307

3.  Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data.

Authors:  Christian Pilarsky; Michael Wenzig; Thomas Specht; Hans Detlev Saeger; Robert Grützmann
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

4.  Overexpression of membrane proteins in primary and metastatic gastrointestinal neuroendocrine tumors.

Authors:  Jennifer C Carr; Scott K Sherman; Donghong Wang; Fadi S Dahdaleh; Andrew M Bellizzi; M Sue O'Dorisio; Thomas M O'Dorisio; James R Howe
Journal:  Ann Surg Oncol       Date:  2013-10-10       Impact factor: 5.344

Review 5.  Molecular screening for breast cancer prevention, early detection, and treatment planning: combining biomarkers from DNA, RNA, and protein.

Authors:  Katherine Stemke-Hale; Bryan Hennessy; Gordon B Mills; Rahul Mitra
Journal:  Curr Oncol Rep       Date:  2006-11       Impact factor: 5.075

6.  Defining NOTCH3 target genes in ovarian cancer.

Authors:  Xu Chen; Michelle M Thiaville; Li Chen; Alexander Stoeck; Jianhua Xuan; Min Gao; Ie-Ming Shih; Tian-Li Wang
Journal:  Cancer Res       Date:  2012-03-06       Impact factor: 12.701

7.  Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma.

Authors:  Ie-Ming Shih; Jim Jinn-Chyuan Sheu; Antonio Santillan; Kentaro Nakayama; M Jim Yen; Robert E Bristow; Russell Vang; Giovanni Parmigiani; Robert J Kurman; Claes G Trope; Ben Davidson; Tian-Li Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

8.  A quantitative reverse transcriptase-polymerase chain reaction assay to identify metastatic carcinoma tissue of origin.

Authors:  Dimitri Talantov; Jonathan Baden; Tim Jatkoe; Kristina Hahn; Jack Yu; Yashoda Rajpurohit; Yiqiu Jiang; Chang Choi; Jeffrey S Ross; David Atkins; Yixin Wang; Abhijit Mazumder
Journal:  J Mol Diagn       Date:  2006-07       Impact factor: 5.568

9.  Interrogating global gene expression in rat neuronal cultures using SAGE.

Authors:  Adriano Sebollela; Emmanuel Dias-Neto; Sérgio T Ferreira
Journal:  Neurotox Res       Date:  2007-12       Impact factor: 3.911

10.  Differentiation of small bowel and pancreatic neuroendocrine tumors by gene-expression profiling.

Authors:  Jennifer C Carr; Erin A Boese; Philip M Spanheimer; Fadi S Dahdaleh; Molly Martin; Daniel Calva; Blanca Schafer; David M Thole; Terry Braun; Thomas M O'Dorisio; M Sue O'Dorisio; James R Howe
Journal:  Surgery       Date:  2012-12       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.